Tag: Antiviral

Pharma / Biotech

Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study.

Newsemia
Related Articles Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study. Antivir Ther. 2019 Dec 04;: Authors: Abreu RM,...
Gastroenterology

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Newsemia
Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram...
Biology

Combinatorial mutagenesis of rapidly evolving residues yields super-restrictor antiviral proteins

Newsemia
by Rossana Colón-Thillet, Emily Hsieh, Laura Graf, Richard N. McLaughlin Jr, Janet M. Young, Georg Kochs, Michael Emerman, Harmit S. Malik Antagonistic interactions drive host–virus...
Pharma / Biotech

Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid.

Newsemia
Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid. Clin Infect Dis. 2019 Sep 27;: Authors: Ma Q, Ocque AJ,...
Biology

Attenuation of chronic antiviral T-cell responses through constitutive COX2-dependent prostanoid synthesis by lymph node fibroblasts

Newsemia
by Karin Schaeuble, Hélène Cannelle, Stéphanie Favre, Hsin-Ying Huang, Susanne G. Oberle, Daniel E. Speiser, Dietmar Zehn, Sanjiv A. Luther Lymphoid T-zone fibroblastic reticular cells...
Surgery/Cosmetic

Antiviral Therapy Improves Post-operative Survival Outcomes in Patients With HBV-related Hepatocellular Carcinoma of Less than 3 cm – A Retrospective Cohort Study

Newsemia
The impact of antiviral therapy on long-term survival outcomes in patients with small HBV-related hepatocellular carcinoma (HBV-related HCC) after liver resection is still controversial, as...
Latest News

Experimental antiviral drug completely protects monkeys from Nipah virus

Newsemia
The experimental antiviral drug remdesivir completely protected four African green monkeys from a lethal dose of Nipah virus, according to a new study in Science...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy